Literature DB >> 25926639

Newcastle Disease Virus-Vectored H7 and H5 Live Vaccines Protect Chickens from Challenge with H7N9 or H5N1 Avian Influenza Viruses.

Qinfang Liu1, Ignacio Mena2, Jingjiao Ma1, Bhupinder Bawa1, Florian Krammer3, Young S Lyoo1, Yuekun Lang1, Igor Morozov1, Gusti Ngurah Mahardika4, Wenjun Ma1, Adolfo García-Sastre5, Juergen A Richt6.   

Abstract

Sporadic human infections by a novel H7N9 virus occurred over a large geographic region in China. In this study, we show that Newcastle disease virus (NDV)-vectored H7 (NDV-H7) and NDV-H5 vaccines are able to induce antibodies with high hemagglutination inhibition (HI) titers and completely protect chickens from challenge with the novel H7N9 or highly pathogenic H5N1 viruses, respectively. Notably, a baculovirus-expressed H7 protein failed to protect chickens from H7N9 virus infection.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25926639      PMCID： PMC4473557          DOI： 10.1128/JVI.00031-15

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  27 in total

1.  Newcastle disease virus-vectored rabies vaccine is safe, highly immunogenic, and provides long-lasting protection in dogs and cats.

Authors:  Jinying Ge; Xijun Wang; Lihong Tao; Zhiyuan Wen; Na Feng; Songtao Yang; Xianzhu Xia; Chinglai Yang; Hualan Chen; Zhigao Bu
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

2.  Induction of cross-reactive antibodies to novel H7N9 influenza virus by recombinant Newcastle disease virus expressing a North American lineage H7 subtype hemagglutinin.

Authors:  Peter H Goff; Florian Krammer; Rong Hai; Christopher W Seibert; Irina Margine; Adolfo García-Sastre; Peter Palese
Journal:  J Virol       Date:  2013-05-22       Impact factor: 5.103

3.  Biological features of novel avian influenza A (H7N9) virus.

Authors:  Jianfang Zhou; Dayan Wang; Rongbao Gao; Baihui Zhao; Jingdong Song; Xian Qi; Yanjun Zhang; Yonglin Shi; Lei Yang; Wenfei Zhu; Tian Bai; Kun Qin; Yu Lan; Shumei Zou; Junfeng Guo; Jie Dong; Libo Dong; Ye Zhang; Hejiang Wei; Xiaodan Li; Jian Lu; Liqi Liu; Xiang Zhao; Xiyan Li; Weijuan Huang; Leying Wen; Hong Bo; Li Xin; Yongkun Chen; Cuilin Xu; Yuquan Pei; Yue Yang; Xiaodong Zhang; Shiwen Wang; Zijian Feng; Jun Han; Weizhong Yang; George F Gao; Guizhen Wu; Dexin Li; Yu Wang; Yuelong Shu
Journal:  Nature       Date:  2013-07-03       Impact factor: 49.962

4.  Development of influenza H7N9 virus like particle (VLP) vaccine: homologous A/Anhui/1/2013 (H7N9) protection and heterologous A/chicken/Jalisco/CPA1/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virus.

Authors:  Gale E Smith; David C Flyer; Ramadevi Raghunandan; Ye Liu; Ziping Wei; Yingyun Wu; Eloi Kpamegan; Denise Courbron; Louis F Fries; Gregory M Glenn
Journal:  Vaccine       Date:  2013-07-26       Impact factor: 3.641

5.  H7N3 live attenuated influenza vaccine has a potential to protect against new H7N9 avian influenza virus.

Authors:  Larisa Rudenko; Irina Isakova-Sivak; Svetlana Donina
Journal:  Vaccine       Date:  2013-08-26       Impact factor: 3.641

6.  Newcastle disease virus-vectored Nipah encephalitis vaccines induce B and T cell responses in mice and long-lasting neutralizing antibodies in pigs.

Authors:  Dongni Kong; Zhiyuan Wen; Hua Su; Jinying Ge; Weiye Chen; Xijun Wang; Chao Wu; Chinglai Yang; Hualan Chen; Zhigao Bu
Journal:  Virology       Date:  2012-06-21       Impact factor: 3.513

7.  Low immunogenicity predicted for emerging avian-origin H7N9: implication for influenza vaccine design.

Authors:  Anne S De Groot; Matthew Ardito; Frances Terry; Lauren Levitz; Ted Ross; Leonard Moise; William Martin
Journal:  Hum Vaccin Immunother       Date:  2013-05-01       Impact factor: 3.452

8.  Efficacy of single dose of a bivalent vaccine containing inactivated Newcastle disease virus and reassortant highly pathogenic avian influenza H5N1 virus against lethal HPAI and NDV infection in chickens.

Authors:  Dong-Hun Lee; Jae-Keun Park; Jung-Hoon Kwon; Seong-Su Yuk; Tseren-Ochir Erdene-Ochir; Yo-Han Jang; Baik-Lin Seong; Joong-Bok Lee; Seung-Yong Park; In-Soo Choi; Chang-Seon Song
Journal:  PLoS One       Date:  2013-03-01       Impact factor: 3.240

9.  Limited airborne transmission of H7N9 influenza A virus between ferrets.

Authors:  Mathilde Richard; Eefje J A Schrauwen; Miranda de Graaf; Theo M Bestebroer; Monique I J Spronken; Sander van Boheemen; Dennis de Meulder; Pascal Lexmond; Martin Linster; Sander Herfst; Derek J Smith; Judith M van den Brand; David F Burke; Thijs Kuiken; Guus F Rimmelzwaan; Albert D M E Osterhaus; Ron A M Fouchier
Journal:  Nature       Date:  2013-08-07       Impact factor: 49.962

10.  The emergence of influenza A H7N9 in human beings 16 years after influenza A H5N1: a tale of two cities.

Authors:  Kelvin K W To; Jasper F W Chan; Honglin Chen; Lanjuan Li; Kwok-Yung Yuen
Journal:  Lancet Infect Dis       Date:  2013-09       Impact factor: 25.071
View more
  27 in total

1.  Recombinant Newcastle disease virus expressing H9 HA protects chickens against heterologous avian influenza H9N2 virus challenge.

Authors:  Abdou Nagy; Jinhwa Lee; Ignacio Mena; Jamie Henningson; Yuhao Li; Jingjiao Ma; Michael Duff; Yonghai Li; Yuekun Lang; Jianmei Yang; Fatma Abdallah; Juergen Richt; Ahmed Ali; Adolfo García-Sastre; Wenjun Ma
Journal:  Vaccine       Date:  2016-04-18       Impact factor: 3.641

2.  Novel Cross-Reactive Monoclonal Antibodies against Ebolavirus Glycoproteins Show Protection in a Murine Challenge Model.

Authors:  James Duehr; Teddy John Wohlbold; Lisa Oestereich; Veronika Chromikova; Fatima Amanat; Madhusudan Rajendran; Sergio Gomez-Medina; Ignacio Mena; Benjamin R tenOever; Adolfo García-Sastre; Christopher F Basler; Cesar Munoz-Fontela; Florian Krammer
Journal:  J Virol       Date:  2017-07-27       Impact factor: 5.103

Review 3.  Vaccines against Major Poultry Viral Diseases: Strategies to Improve the Breadth and Protective Efficacy.

Authors:  Rajamanonmani Ravikumar; Janlin Chan; Mookkan Prabakaran
Journal:  Viruses       Date:  2022-05-31       Impact factor: 5.818

4.  Protective Efficacy of Recombinant Turkey Herpes Virus (rHVT-H5) and Inactivated H5N1 Vaccines in Commercial Mulard Ducks against the Highly Pathogenic Avian Influenza (HPAI) H5N1 Clade 2.2.1 Virus.

Authors:  Walid H Kilany; Marwa Safwat; Samy M Mohammed; Abdullah Salim; Folorunso Oludayo Fasina; Olubunmi G Fasanmi; Azhar G Shalaby; Gwenaelle Dauphin; Mohammed K Hassan; Juan Lubroth; Yilma M Jobre
Journal:  PLoS One       Date:  2016-06-15       Impact factor: 3.240

5.  Characterizations of H4 avian influenza viruses isolated from ducks in live poultry markets and farm in Shanghai.

Authors:  Ying Shi; Hongrui Cui; Junheng Wang; Qiuyan Chi; Xuesong Li; Qiaoyang Teng; Hongjun Chen; Jianmei Yang; Qinfang Liu; Zejun Li
Journal:  Sci Rep       Date:  2016-11-29       Impact factor: 4.379

6.  An increasing trend of rural infections of human influenza A (H7N9) from 2013 to 2017: A retrospective analysis of patient exposure histories in Zhejiang province, China.

Authors:  Enfu Chen; Maggie H Wang; Fan He; Riyang Sun; Wei Cheng; Benny C Y Zee; Steven Y F Lau; Xiaoxiao Wang; Ka Chun Chong
Journal:  PLoS One       Date:  2018-02-15       Impact factor: 3.240

7.  Newcastle disease virus-vectored West Nile fever vaccine is immunogenic in mammals and poultry.

Authors:  Jinliang Wang; Jie Yang; Jinying Ge; Ronghong Hua; Renqiang Liu; Xiaofeng Li; Xijun Wang; Yu Shao; Encheng Sun; Donglai Wu; Chengfeng Qin; Zhiyuan Wen; Zhigao Bu
Journal:  Virol J       Date:  2016-06-24       Impact factor: 4.099

8.  Chimeric Bivalent Virus-Like Particle Vaccine for H5N1 HPAI and ND Confers Protection against a Lethal Challenge in Chickens and Allows a Strategy of Differentiating Infected from Vaccinated Animals (DIVA).

Authors:  Jin-Yong Noh; Jae-Keun Park; Dong-Hun Lee; Seong-Su Yuk; Jung-Hoon Kwon; Sang-Won Lee; Joong-Bok Lee; Seung-Yong Park; In-Soo Choi; Chang-Seon Song
Journal:  PLoS One       Date:  2016-09-14       Impact factor: 3.240

Review 9.  Viral vector-based influenza vaccines.

Authors:  Rory D de Vries; Guus F Rimmelzwaan
Journal:  Hum Vaccin Immunother       Date:  2016-07-25       Impact factor: 3.452

Review 10.  Challenges of influenza A viruses in humans and animals and current animal vaccines as an effective control measure.

Authors:  Sung J Yoo; Taeyong Kwon; Young S Lyoo
Journal:  Clin Exp Vaccine Res       Date:  2018-01-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.